Nel ASA's Autumn Calendar Is Set — Now the Hard Questions Begin

Nel ASA schedules Q3 report for Oct 21 and FY2026 results for Feb 19, 2027, as shares trade 46% below 52-week high and CEO departure looms.

The Norwegian hydrogen specialist has given investors something it has been short on lately: certainty about when the next big moments of truth will arrive. Nel ASA's financial calendar for the coming two years is now public, with the third-quarter report locked in for October 21 and full-year 2026 results scheduled for February 19, 2027.

It is a modest piece of housekeeping, to be sure. But for a company navigating a CEO departure, a bruising earnings season and persistent analyst skepticism, knowing exactly when the next data points land matters more than usual.

A Stock Still Digging Out of a Hole

The market's reaction to the calendar announcement was telling in its absence. Shares traded at €0.1958 on Friday, roughly 3 percent below their 50-day moving average of €0.2018 — a sign that the short-term trend remains tilted downward even as the stock has found a temporary floor.

The bigger picture is starker. The shares sit approximately 46 percent below their 52-week high of €0.3655, a peak reached in late May. The year-over-year decline stands at 4.0 percent, underscoring that the recovery from February's lows has failed to gain lasting traction. On Thursday, the stock closed at €0.1946, putting it 47 percent off that same high-water mark.

The Operating Picture Remains the Core Problem

The calendar release itself carried no operational news — it merely maps out when the numbers will come. But the numbers already on the table continue to weigh on sentiment. Nel's second-quarter 2026 results showed order intake of 230 million Norwegian kroner and a backlog of 1.213 billion kroner, against an EBITDA loss of minus 155 million kroner. Revenue from customer contracts came in at 153 million kroner.

Those figures are now more than a month old, yet they still shape how the market views the company. The operational loss widened noticeably, and the order picture — while not collapsing — has not yet convinced skeptics that a turnaround is underway.

Adding to the strain is the impending exit of CEO Håkon Volldal, who is set to step down by year-end and has since been confirmed to be joining Elopak. No successor has been named. A leadership transition is never easy; one occurring while the company is trying to steady its financial footing makes the upcoming reporting dates doubly important as moments to gauge strategic direction.

Small Wins, But Not Enough to Move the Needle

There have been flickers of positive news, even if they have not registered in the share price. Cavendish Hydrogen, the Nel spin-off now operating independently, secured an order for a hydrogen refueling station in Luxembourg alongside partner Mesure Process. The parent company, meanwhile, booked a $7 million order for containerized PEM electrolyzers.

These are modest contract wins, but they offer at least some evidence that demand for hydrogen technology has not evaporated. Whether they signal a durable improvement in order flow — or merely isolated successes — is the question investors will be asking when the Q3 report lands on October 21.

What the Autumn Report Must Show

The market's focus is narrowing to a handful of metrics. Can Nel sustain the recent uptick in order intake? Will the company stabilize its shrinking cash reserves? And can it demonstrate that the operational deterioration visible in the first half is being arrested?

JPMorgan's decision to trim its price target roughly three weeks ago reflects the prevailing mood of caution. The technical picture — with the stock trading well below its longer-term moving averages — aligns with that fundamental skepticism.

The financial calendar does not answer any of these questions. What it does is set the stage for them to be asked, repeatedly, over the next two years. For Nel shareholders, that means the autumn report is no longer just another earnings date. It is the first real test of whether the company can offer something beyond a schedule of upcoming disappointments.